'Haley and DeSantis have infinitely less to account and apologize for than Trump does'
Frank Bruni in The New York Times
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
'Young voters are ripe for President Biden's taking'
Victor Shi in USA Today
The "hungriest constituency" determines elections, says Victor Shi in USA Today. "Historic" Black turnout lifted Barack Obama to victory, twice. Enthusiastic women voters clinched Hillary Clinton's 2016 Democratic nomination. The group President Joe Biden needs is "young voters." Polls suggest he's losing them, but he isn't. He just needs to make them see his achievements on issues "from climate change to student loan forgiveness to gun violence," and show he can play "hardball" with Republicans.
'Donald Trump and his allies have come up short'
Norman Eisen, Richard W. Painter, and Joyce Vance in The Atlanta Journal-Constitution
The "sensational" allegation of impropriety against Fulton County, Georgia, District Attorney Fani Willis won't let Donald Trump off the hook, say Norman Eisen, Richard W. Painter, and Joyce Vance in The Atlanta Journal-Constitution. One of Trump's Georgia election-subversion co-defendants, GOP operative Michael Roman, claims Willis is romantically involved with the special prosecutor she hired, Nathan Wade. Even if the allegation were true, "a big if," it wouldn't justify Trump's call for dismissal "under Georgia law."
'No one has a God-given right to have someone create "free" new treatments for their disease'
Christopher Jacobs in The Federalist
Pharmaceutical companies responded quickly to Medicare drug price controls Democrats "rammed through," says Christopher Jacobs in The Federalists. The rules give companies limited years to market new medicines before price "negotiation" starts. "Companies whose drugs could treat multiple medical conditions, such as different types of cancer," have started slow-walking some trials to get approval "for the broadest possible condition first," to maximize profits. Patients who need new drugs for rare diseases are the "ultimate losers."
-
Jaguar Land Rover’s cyber bailoutTalking Point Should the government do more to protect business from the ‘cyber shockwave’?
-
Russia: already at war with Europe?Talking Point As Kremlin begins ‘cranking up attacks’ on Ukraine’s European allies, questions about future action remain unanswered
-
Sudoku hard: October 5, 2025The Week's daily hard sudoku puzzle
-
Russia: already at war with Europe?
Talking Point As Kremlin begins ‘cranking up attacks’ on Ukraine’s European allies, questions about future action remain unanswered
-
‘Conspiracy theories about her disappearance do a disservice’Instant Opinion Opinion, comment and editorials of the day
-
Trump declares ‘armed conflict’ with drug cartelsspeed read This provides a legal justification for recent lethal military strikes on three alleged drug trafficking boats
-
Supreme Court rules for Fed’s Cook in Trump feudSpeed Read Federal Reserve Governor Lisa Cook can remain in her role following Trump’s attempts to oust her
-
‘This isn’t just semantics’Instant Opinion Opinion, comment and editorials of the day
-
Miami Freedom Tower’s MAGA library squeezeTHE EXPLAINER Plans to place Donald Trump’s presidential library next to an iconic symbol of Florida’s Cuban immigrant community has South Florida divided
-
Judge rules Trump illegally targeted Gaza protestersSpeed Read The Trump administration’s push to arrest and deport international students for supporting Palestine is deemed illegal
-
Trump: US cities should be military ‘training grounds’Speed Read In a hastily assembled summit, Trump said he wants the military to fight the ‘enemy within’ the US
